{"id":"https://openalex.org/W4391309738","doi":"https://doi.org/10.1001/jamainternmed.2023.7660","title":"Sodium-Glucose Cotransporter 2 Inhibitors and Nephrolithiasis Risk in Patients With Type 2 Diabetes","display_name":"Sodium-Glucose Cotransporter 2 Inhibitors and Nephrolithiasis Risk in Patients With Type 2 Diabetes","publication_year":2024,"publication_date":"2024-01-29","ids":{"openalex":"https://openalex.org/W4391309738","doi":"https://doi.org/10.1001/jamainternmed.2023.7660","pmid":"https://pubmed.ncbi.nlm.nih.gov/38285598","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10825784"},"language":"en","primary_location":{"id":"doi:10.1001/jamainternmed.2023.7660","doi":"https://doi.org/10.1001/jamainternmed.2023.7660","is_oa":false,"landing_page_url":"https://doi.org/10.1001/jamainternmed.2023.7660","pdf_url":null,"source":{"id":"https://openalex.org/S65364685","display_name":"JAMA Internal Medicine","issn_l":"2168-6106","issn":["2168-6106","2168-6114"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320259","host_organization_name":"American Medical Association","host_organization_lineage":["https://openalex.org/P4310320259"],"host_organization_lineage_names":["American Medical Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA Internal Medicine","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://pmc.ncbi.nlm.nih.gov/articles/instance/10825784/bin/jamainternmed-e237660-s001.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5085331349","display_name":"Julie M. Paik","orcid":"https://orcid.org/0000-0002-1315-5445","observed_orcids":["https://orcid.org/0000-0002-1315-5445"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I2801671727","display_name":"VA Boston Healthcare System","ror":"https://ror.org/04v00sg98","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I2801671727","https://openalex.org/I4210095851"]},{"id":"https://openalex.org/I4405286203","display_name":"New England Geriatric Research Education and Clinical Center","ror":"https://ror.org/01e7jsw68","country_code":"US","type":"government","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I2800300635","https://openalex.org/I2801671727","https://openalex.org/I4210095851","https://openalex.org/I4405286203"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Julie M. Paik","raw_affiliation_strings":["Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women\u2019s Hospital, Boston, Massachusetts","Division of Renal (Kidney) Medicine, Department of Medicine, Brigham and Women\u2019s Hospital, Boston, Massachusetts","Harvard Medical School, Boston, Massachusetts","New England Geriatric Research, Education and Clinical Center, VA Boston Healthcare System, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women\u2019s Hospital, Boston, Massachusetts","institution_ids":["https://openalex.org/I1283280774"]},{"raw_affiliation_string":"Division of Renal (Kidney) Medicine, Department of Medicine, Brigham and Women\u2019s Hospital, Boston, Massachusetts","institution_ids":["https://openalex.org/I1283280774"]},{"raw_affiliation_string":"Harvard Medical School, Boston, Massachusetts","institution_ids":["https://openalex.org/I136199984"]},{"raw_affiliation_string":"New England Geriatric Research, Education and Clinical Center, VA Boston Healthcare System, Boston, Massachusetts","institution_ids":["https://openalex.org/I2801671727","https://openalex.org/I4405286203"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074777366","display_name":"Helen Tesfaye","orcid":"https://orcid.org/0000-0002-6264-2813","observed_orcids":["https://orcid.org/0000-0002-6264-2813"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Helen Tesfaye","raw_affiliation_strings":["Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women\u2019s Hospital, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women\u2019s Hospital, Boston, Massachusetts","institution_ids":["https://openalex.org/I1283280774"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051186379","display_name":"Gary C. Curhan","orcid":"https://orcid.org/0000-0001-7386-6305","observed_orcids":["https://orcid.org/0000-0001-7386-6305"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gary C. Curhan","raw_affiliation_strings":["Division of Renal (Kidney) Medicine, Department of Medicine, Brigham and Women\u2019s Hospital, Boston, Massachusetts","Harvard Medical School, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Renal (Kidney) Medicine, Department of Medicine, Brigham and Women\u2019s Hospital, Boston, Massachusetts","institution_ids":["https://openalex.org/I1283280774"]},{"raw_affiliation_string":"Harvard Medical School, Boston, Massachusetts","institution_ids":["https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047891240","display_name":"Heidi Zakoul","orcid":"https://orcid.org/0009-0008-3022-9013","observed_orcids":["https://orcid.org/0009-0008-3022-9013"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Heidi Zakoul","raw_affiliation_strings":["Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women\u2019s Hospital, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women\u2019s Hospital, Boston, Massachusetts","institution_ids":["https://openalex.org/I1283280774"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076997901","display_name":"Deborah J. Wexler","orcid":"https://orcid.org/0000-0001-6979-402X","observed_orcids":["https://orcid.org/0000-0001-6979-402X"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Deborah J. Wexler","raw_affiliation_strings":["Diabetes Center, Massachusetts General Hospital, Boston, Massachusetts","Harvard Medical School, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Diabetes Center, Massachusetts General Hospital, Boston, Massachusetts","institution_ids":["https://openalex.org/I4210087915"]},{"raw_affiliation_string":"Harvard Medical School, Boston, Massachusetts","institution_ids":["https://openalex.org/I136199984"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5044474781","display_name":"Elisabetta Patorno","orcid":"https://orcid.org/0000-0002-8809-9898","observed_orcids":["https://orcid.org/0000-0002-8809-9898"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elisabetta Patorno","raw_affiliation_strings":["Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women\u2019s Hospital, Boston, Massachusetts","Harvard Medical School, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women\u2019s Hospital, Boston, Massachusetts","institution_ids":["https://openalex.org/I1283280774"]},{"raw_affiliation_string":"Harvard Medical School, Boston, Massachusetts","institution_ids":["https://openalex.org/I136199984"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5085331349"],"corresponding_institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984","https://openalex.org/I2801671727","https://openalex.org/I4405286203"],"apc_list":null,"apc_paid":null,"fwci":17.2838,"has_fulltext":true,"cited_by_count":53,"citation_normalized_percentile":{"value":0.99454436,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":99,"max":100},"biblio":{"volume":"184","issue":"3","first_page":"265","last_page":"265"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.5863999724388123,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.5863999724388123,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10606","display_name":"Kidney Stones and Urolithiasis Treatments","score":0.3700999915599823,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10408","display_name":"Chronic Kidney Disease and Diabetes","score":0.010499999858438969,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sglt2-inhibitors","display_name":"SGLT2 inhibitors","score":0.9750000238418579},{"id":"https://openalex.org/keywords/kidney-stones","display_name":"kidney stones","score":0.9800000190734863},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9980000257492065},{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.9419999718666077},{"id":"https://openalex.org/keywords/dpp-4-inhibitors","display_name":"DPP-4 inhibitors","score":0.9950000047683716},{"id":"https://openalex.org/keywords/antidiabetic-drug-safety","display_name":"antidiabetic drug safety","score":0.6069999933242798},{"id":"https://openalex.org/keywords/urinary-oxalate","display_name":"urinary oxalate","score":0.6970000267028809},{"id":"https://openalex.org/keywords/urinary-citrate","display_name":"urinary citrate","score":0.5099999904632568},{"id":"https://openalex.org/keywords/urine-ph","display_name":"urine pH","score":0.36800000071525574},{"id":"https://openalex.org/keywords/drug-induced-nephrolithiasis","display_name":"drug-induced nephrolithiasis","score":0.5189999938011169}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9522063732147217},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.7084852457046509},{"id":"https://openalex.org/C17923572","wikidata":"https://www.wikidata.org/wiki/Q7250160","display_name":"Propensity score matching","level":2,"score":0.6479211449623108},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.6451013088226318},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6140649914741516},{"id":"https://openalex.org/C2781308992","wikidata":"https://www.wikidata.org/wiki/Q2526479","display_name":"Liraglutide","level":4,"score":0.5364513993263245},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5067461133003235},{"id":"https://openalex.org/C156490143","wikidata":"https://www.wikidata.org/wiki/Q412214","display_name":"Dipeptidyl peptidase-4","level":4,"score":0.4597793221473694},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.44884806871414185},{"id":"https://openalex.org/C2779668873","wikidata":"https://www.wikidata.org/wiki/Q6693756","display_name":"Lower risk","level":3,"score":0.42758437991142273},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.41427135467529297},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.30555224418640137},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.14469444751739502}],"mesh":[{"descriptor_ui":"D000067757","descriptor_name":"Glucagon-Like Peptide-1 Receptor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005947","descriptor_name":"Glucose","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007297","descriptor_name":"Inpatients","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012964","descriptor_name":"Sodium","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015331","descriptor_name":"Cohort Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053040","descriptor_name":"Nephrolithiasis","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D053040","descriptor_name":"Nephrolithiasis","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D054873","descriptor_name":"Dipeptidyl-Peptidase IV Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1001/jamainternmed.2023.7660","doi":"https://doi.org/10.1001/jamainternmed.2023.7660","is_oa":false,"landing_page_url":"https://doi.org/10.1001/jamainternmed.2023.7660","pdf_url":null,"source":{"id":"https://openalex.org/S65364685","display_name":"JAMA Internal Medicine","issn_l":"2168-6106","issn":["2168-6106","2168-6114"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320259","host_organization_name":"American Medical Association","host_organization_lineage":["https://openalex.org/P4310320259"],"host_organization_lineage_names":["American Medical Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA Internal Medicine","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10825784","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10825784","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/instance/10825784/bin/jamainternmed-e237660-s001.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA Intern Med","raw_type":"Text"},{"id":"pmid:38285598","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/38285598","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA internal medicine","raw_type":"Journal Article"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:10825784","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10825784","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/instance/10825784/bin/jamainternmed-e237660-s001.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA Intern Med","raw_type":"Text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[{"id":"https://openalex.org/G3417008487","display_name":"Acid-Base Status as a Novel Risk Factor for Fractures","funder_award_id":"R01AR075117","funder_id":"https://openalex.org/F4320337362","funder_display_name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases"},{"id":"https://openalex.org/G4581603693","display_name":"Novel Approaches to Monitor the Safety and Effectiveness of Newly Marketed Diabetes Medications in Older Adults Considering Frailty and Multimorbidity","funder_award_id":"K08AG055670","funder_id":"https://openalex.org/F4320337337","funder_display_name":"National Institute on Aging"}],"funders":[{"id":"https://openalex.org/F4320337337","display_name":"National Institute on Aging","ror":"https://ror.org/049v75w11"},{"id":"https://openalex.org/F4320337362","display_name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","ror":"https://ror.org/006zn3t30"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4391309738.pdf","grobid_xml":"https://content.openalex.org/works/W4391309738.grobid-xml"},"referenced_works_count":36,"referenced_works":["https://openalex.org/W1986603446","https://openalex.org/W2079717293","https://openalex.org/W2087018232","https://openalex.org/W2118744783","https://openalex.org/W2146845152","https://openalex.org/W2158197611","https://openalex.org/W2160571874","https://openalex.org/W2171021142","https://openalex.org/W2219239410","https://openalex.org/W2503745853","https://openalex.org/W2524330917","https://openalex.org/W2765979443","https://openalex.org/W2788464339","https://openalex.org/W2793811202","https://openalex.org/W2802163140","https://openalex.org/W2886965183","https://openalex.org/W2967923511","https://openalex.org/W3015408813","https://openalex.org/W3082832108","https://openalex.org/W3083908125","https://openalex.org/W3092379111","https://openalex.org/W3103925419","https://openalex.org/W3131824613","https://openalex.org/W3136223938","https://openalex.org/W4221024385","https://openalex.org/W4221079817","https://openalex.org/W4225985041","https://openalex.org/W4226194805","https://openalex.org/W4230866161","https://openalex.org/W4246512162","https://openalex.org/W4255918632","https://openalex.org/W4281560562","https://openalex.org/W4293802544","https://openalex.org/W4304204676","https://openalex.org/W4307721343","https://openalex.org/W4319004581"],"related_works":["https://openalex.org/W4282002954","https://openalex.org/W3136223938","https://openalex.org/W4405314599","https://openalex.org/W4411436720","https://openalex.org/W4408170409","https://openalex.org/W4381377379","https://openalex.org/W4415354151","https://openalex.org/W4415381290","https://openalex.org/W7214758358","https://openalex.org/W4401439473"],"abstract_inverted_index":{"Importance:":[0],"Type":[1],"2":[2,16],"diabetes":[3],"(T2D)":[4],"is":[5],"associated":[6],"with":[7,83,88,180,197,352,398,409],"an":[8,124,203,233,275],"increased":[9],"risk":[10,22,41,60,267,331,350,405,429],"of":[11,23,123,142,162,193,261,268,340,348,406],"kidney":[12,342],"stones.":[13],"Sodium-glucose":[14],"cotransporter":[15],"inhibitors":[17,100],"(SGLT2is)":[18],"might":[19],"lower":[20,271,403],"the":[21,34,48,53,146,266,349,404],"nephrolithiasis":[24,40,59,137,269,330,407],"by":[25,139,334],"altering":[26],"urine":[27],"composition.":[28],"However,":[29],"no":[30],"studies":[31],"have":[32],"investigated":[33],"association":[35,54,325],"between":[36,55,102,326],"SGLT2i":[37,56,152,204,234,276,327,353,400],"use":[38,57,328,354,401],"and":[39,58,66,106,131,175,225,329,337,344,390,413],"in":[42,47,61,145,167,272,396],"patients":[43,273,424],"receiving":[44],"routine":[45],"care":[46],"US.":[49],"Objective:":[50],"To":[51],"investigate":[52],"clinical":[62],"practice.":[63],"Design,":[64],"Setting,":[65],"Participants:":[67],"This":[68],"new-user,":[69],"active":[70],"comparator":[71],"cohort":[72],"study":[73],"used":[74],"data":[75,111],"from":[76,114],"commercially":[77],"insured":[78],"adults":[79,196,228,358,397],"(aged":[80],"\u226518":[81],"years)":[82],"T2D":[84,198],"who":[85,425],"initiated":[86],"treatment":[87],"SGLT2is,":[89],"glucagon-like":[90],"peptide":[91],"1":[92],"receptor":[93],"agonists":[94],"(GLP-1RAs),":[95],"or":[96,127,148,165,205,235,302,368,411],"dipeptidyl":[97],"peptidase":[98],"4":[99],"(DPP4is)":[101],"April":[103],"1,":[104],"2013,":[105],"December":[107],"31,":[108],"2020.":[109],"The":[110,133,324,346],"were":[112,154,183,255],"analyzed":[113],"July":[115],"2021":[116],"through":[117],"June":[118],"2023.":[119],"Exposure:":[120],"New":[121,151],"initiation":[122],"SGLT2i,":[125],"GLP-1RA,":[126],"DPP4i.":[128],"Main":[129],"Outcomes":[130],"Measures:":[132],"primary":[134],"outcome":[135],"was":[136,270,332,355],"diagnosed":[138],"International":[140],"Classification":[141],"Diseases":[143],"codes":[144],"inpatient":[147],"outpatient":[149],"setting.":[150],"users":[153,161],"1:1":[155,187],"propensity":[156,188],"score":[157,189],"matched":[158],"to":[159,300,322,380,416],"new":[160],"a":[163,191,206,236,258,281,303],"GLP-1RA":[164,207,282],"DPP4i":[166,237,304],"pairwise":[168],"comparisons.":[169],"Incidence":[170],"rates,":[171],"rate":[172],"differences":[173],"(RDs),":[174],"estimated":[176],"hazard":[177],"ratios":[178],"(HRs)":[179],"95%":[181],"CIs":[182],"calculated.":[184],"Results:":[185],"After":[186],"matching,":[190],"total":[192],"716":[194],"406":[195],"(358":[199],"203":[200],"pairs)":[201,231],"initiating":[202,232,274,280],"(mean":[208,238],"[SD]":[209,239],"age,":[210,240],"61.4":[211],"[9.7]":[212],"years":[213,363,367],"for":[214,386,423,430],"both":[215],"groups;":[216],"51.4%":[217],"vs":[218,222,243,248,252,284,306,364],"51.2%":[219],"female;":[220,250],"48.6%":[221],"48.5%":[223],"male)":[224,254],"662":[226],"056":[227],"(331":[229],"028":[230],"61.8":[241],"[9.3]":[242],"61.7":[244],"[10.1]":[245],"years;":[246],"47.4%":[247],"47.3%":[249],"52.6%":[251],"52.7%":[253],"included.":[256],"Over":[257],"median":[259],"follow-up":[260],"192":[262],"(IQR,":[263],"88-409)":[264],"days,":[265],"than":[277,361],"among":[278,357],"those":[279],"(14.9":[283],"21.3":[285],"events":[286,308],"per":[287,309,382],"1000":[288,310,383],"person-years;":[289,311,384],"HR,":[290,312],"0.69":[291],"[95%":[292,297,314,319,372,377],"CI,":[293,298,315,320,373,378],"0.67-0.72];":[294],"RD,":[295,317,375],"-6.4":[296],"-7.1":[299],"-5.7])":[301],"(14.6":[305],"19.9":[307],"0.74":[313],"0.71-0.77];":[316],"-5.3":[318],"-6.0":[321],"-4.6]).":[323],"similar":[333],"sex,":[335],"race":[336],"ethnicity,":[338],"history":[339],"chronic":[341],"disease,":[343],"obesity.":[345],"magnitude":[347],"reduction":[351],"larger":[356],"aged":[359,365],"younger":[360],"70":[362,366],"older":[369],"(HR,":[370],"0.85":[371],"0.79-0.91];":[374],"-3.46":[376],"-4.87":[379],"-2.05]":[381],"P":[385],"interaction":[387],"<.001).":[388],"Conclusions":[389],"Relevance:":[391],"These":[392],"findings":[393],"suggest":[394],"that":[395],"T2D,":[399],"may":[402,426],"compared":[408],"GLP-1RAs":[410],"DPP4is":[412],"could":[414],"help":[415],"inform":[417],"decision-making":[418],"when":[419],"prescribing":[420],"glucose-lowering":[421],"agents":[422],"be":[427],"at":[428],"developing":[431],"nephrolithiasis.":[432]},"counts_by_year":[{"year":2026,"cited_by_count":13},{"year":2025,"cited_by_count":22},{"year":2024,"cited_by_count":18}],"updated_date":"2026-11-03T10:50:19.383937","created_date":"2024-01-30T00:00:00"}